Trial
NCT02050321
A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Arizona
Collaborators
—
Condition
Malignant Melanoma
Intervention
Acitretin
Why stopped
Pharmaceutical company pulled support for the trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-12-26